Neurol. praxi. 2010;11(3):188-190

Antiepileptics in psychiatry

prof.MUDr.Eva Češková, CSc.
Psychiatrická klinika LF MU a FN Brno

Based on controlled studies valproate, carbamazepine and lamotrigine have a firm position in the treatment of bipolar disorder. Besides

lithium they are considered to be the most important representatives of mood stabilizers (MS). According to available guidelines MS are

recommended in all phases of bipolar disorder. The aim of this retrospective study was to assess the treatment of bipolar disorder in

clinical practice. Analyzing charts of patients we found that totally 71 patients (37 female, 34 male) were hospitalized 92 times (35 with

mania, 53 with depression) during the 2-year period. In both mania and depression the most frequently used treatment strategy was the

combination of MS and atypical antipsychotic. This is corresponding with the data about a more robust effect of combination in severe

disorders requiring hospitalization. The most frequently used MS was valproate, the most frequently used antipsychotics were olanzapine

and quetiapine. However, with long-term treatment the issue of side effects has to be considered (weight increase, teratogenity).

Keywords: antiepileptics, bipolar disorder, mood stabilizers, atypical antipsychotics, combination

Published: June 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Češková E. Antiepileptics in psychiatry. Neurol. praxi. 2010;11(3):188-190.
Download citation

References

  1. Barclay L. FDA reviews risk for suicide associated with antiepileptic drugs. www.medscape.com/viewarticle/576115.
  2. Blumberg HP, Krystal JH, Bansal R, Martin A, Dziura J, Durkin K, Martin I, Gerard E, Charney DS, Peterson BS. Age, rapidcycling, and pharmacotherapy effects on centrál prefrontal cortex in bipolar diosrder: a Gross-sectional study. Biol Psychiatry 2006; 59: 611-618. Go to original source... Go to PubMed...
  3. Bowden CL, Edwards S, Evoniuk G. Open-label, concomitant use of lamotrigine and other medications for bipolar disorder. CNS Spectr 2008; 13: 75-83. Go to original source... Go to PubMed...
  4. Češková E, Herman E, Doubek P, Praško J. Bipolární afektivní porucha. V: Raboch J, Anders M, Praško J, Kellerová P. Psychiatrie. Doporučené postupy léčby psychiatrické péče II. Praha: Infopharm 2006; 88-96.
  5. Fountoulakis KN, Vieta E. Treatment of bipolar disorder. A systematic review of available data and clinical perspectives. Int J Neuropsychopharmacol 2008; 11: 999-1029. Go to original source... Go to PubMed...
  6. Freeman MP. Bipolar disorder and pregnancy: risks revealed. Am J Psychiatry 2007; 164: 1771-1773. Go to original source... Go to PubMed...
  7. Grunze HC. The effectiveness of anticonvulsants in psychiatric disorders. Dialogue Clin Neurosci 2008; 10: 77-90. Go to original source...
  8. Harden CL, Leppik I. Optimizing therapy of seizures in women who use oral contraceptives. Neurology 2006; 67: S56-8. Go to original source... Go to PubMed...
  9. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, Leon AC, Rice JA, Keller MB. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59: 530-537. Go to original source... Go to PubMed...
  10. McElroy SL, Guerdjikova AI, Martens B, Keck PE Jr, Pope HG, Hudson JI. Role of antiepileptic drugs in the management of eating disorders. CNS Drugs 2009; 23: 139-56. Go to original source... Go to PubMed...
  11. McIntyre RS, Soczynska JK, Beyer JL, Woldeyohannes HO, Law CW, Miranda A, Konarski JZ, Kennedy SH. Medical comorbidity in bipolar disorder: re-priotizing umet needs. J Curr Opin Psychiatry 2007; 20: 406-416. Go to original source... Go to PubMed...
  12. Sintzel F, Mallaret M, Bougerol T. Potentializing of tricyclics and serotoninergics by thyroid hormones in resistant depressive diosrders. Encephale 2004; 30: 267-275. Go to original source... Go to PubMed...
  13. Smith LA, Cormelius V, Warmock A, Tacchi MJ, Taylor D. Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy. Acta Psychiatr Scand 2007; 115: 12-20. Go to original source... Go to PubMed...
  14. Steinfoff BJ. Pregnancy, epilepsy, and anticonvulsants. Dialogue Clin Neurosci 2008; 10: 63-75. Go to original source...
  15. Torrent C, Amann B, Sánchez-Moreno J, Colom F, Reinares M, Rosa AR, Scott J, Viela E. Weight gain in bipolar disorder: pharmacological treatment as a contributing factor. Acta Psychiatr Scand 2008; 118: 4-18. Go to original source... Go to PubMed...
  16. Yong AH, Hammond JM. Lithium in mood disorders. Increasing evidence base, declining use? Br J Psychiatry, 191, 2007; 191: 474-476. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.